Archive for Publications

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12CMutated Metastatic Colorectal Cancer

A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors

A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma

A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors

PHASE 1 FIRST-IN- HUMAN STUDY OF DALUTRAFUSP ALFA,

Cluster of differentiation (CD)73-adenosine and transforming growth factor (TGF)-β pathways are involved in abrogated antitumor immune responses and can lead to protumor conditions….

RARE SOLID AND CYSTIC PRESENTATION OF HEMANGIOPERICYTOMA/ SOLITARY FIBROUS TUMOR: A CASE REPORT

MANUFACTURING-DEPENDENT CHANGE IN BIOLOGICAL ACTIVITY OF THE TLR4 AGONIST GSK1795091

EFFECT OF PEVONEDISTAT, AN INVESTIGATIONAL NEDD8-ACTIVATING ENZYME INHIBITOR

NEW ENGLAND JOURNAL OF MEDICINE: ADAGRASIB WITH OR WITHOUT CETUXIMAB IN COLORECTAL CANCERWITH MUTATED KRAS G12C

See Mary Crowley featured in the New England Journal of Medicine.

A PHASE I, OPEN-LABEL, DOSE CONFIRMATION, ESCALATION, AND EXPANSION TRIAL OF BI 1810631